Showing results (1091-1100 of 4,506) with videos related to

Sort By:
Pageof 451
Advances in Therapy|September 6, 2026
Real-World Longitudinal Treatment Outcomes for Patients with Metastatic Castration-Sensitive Prostate Cancer in JapanTaketo Kawai, Fumiko Kiyonaga, Satoshi Uno, et al.
Advances in Therapy|September 24, 2022
A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with PolyangiitisHaruki Koike, Ryoji Nishi, Satoru Yagi, et al.
Advances in Therapy|October 26, 2022
Peripheral Treg Levels and Transforming Growth Factor-β (TGFβ) in Patients with Psoriatic Arthritis: A Systematic Review Meta-AnalysisQin-Yi Su, Sheng-Xiao Zhang, Liu Yang, et al.
Advances in Therapy|October 15, 2022
The Rise of Prescription Digital Therapeutics in Behavioral HealthChristina A Brezing, Diana I Brixner
Advances in Therapy|October 14, 2022
Real-World Analysis of Treatment Patterns, Healthcare Utilization, Costs, and Mortality Among People with Biliary Tract Cancers in the USAMarcus J Healey, Brian Seal, Nicole Princic, et al.
Advances in Therapy|October 14, 2022
The Hidden Burden of Disease and Treatment Experiences of Patients with Essential Tremor: A Retrospective Claims Data AnalysisChristine Vetterick, Kelly E Lyons, Lillian G Matthews, et al.
Advances in Therapy|September 11, 2022
Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) StudyTakao Takeshima, Kaname Ueda, Mika Komori, et al.
Advances in Therapy|December 7, 2014
The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset modelKarthik Ramakrishnan, Peter Braunhofer, Britt Newsome, et al.
Advances in Therapy|November 22, 2014
No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosisRichard Nixon, Niklas Bergvall, Davorka Tomic, et al.
Advances in Therapy|November 5, 2015
Effects of Baseline Blood Pressure and Low-Density Lipoprotein Cholesterol on Safety and Efficacy of Canagliflozin in Japanese Patients with Type 2 Diabetes MellitusNobuya Inagaki, Maki Goda, Shoko Yokota, et al.
Pageof 451